文献速递慢病防控与筛查卫生政策与健康促进

美国药物与阿片类药物过量死亡:2013–2017年

Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2018-01-04

CDC分析2013–2017年美国50州及DC的药物过量死亡率,2017年70,237例药物过量死亡中47,600例(67.8%)涉及阿片类。2013–2017年35个州及DC药物过量死亡率上升,20州中15州合成阿片类死亡率显著上升,主要由非法制造芬太尼驱动。2016–2017年全阿片类和合成阿片类死亡率上升,但处方阿片类和海洛因死亡率保持稳定。

要点

  • 2017年67.8%的药物过量死亡涉及阿片类。
  • 2013–2017年合成阿片类死亡率在20州中15州显著上升。
  • 2016–2017年处方阿片类和海洛因死亡率保持稳定。

核心结论

  • 阿片类过量死亡疫情因合成阿片类死亡持续增加而恶化和演变。
  • 2016–2017年全阿片类和合成阿片类过量死亡增加,但处方阿片类和海洛因死亡保持稳定。

研究设计与样本

  • CDC分析2013–2017年50州及DC全药物过量死亡率变化。
  • 分析20州合成阿片类死亡率变化。
  • 分析2016–2017年全阿片类及阿片类亚类死亡率按人口学、县城市化水平和34州及DC的变化。

主要发现

  • 2017年70,237例药物过量死亡中47,600例(67.8%)涉及阿片类。
  • 2013–2017年50州中35州及DC药物过量死亡率上升。
  • 2013–2017年20州中15州合成阿片类死亡率显著上升,可能由非法制造芬太尼驱动。
  • 2016–2017年涉及全阿片类和合成阿片类的过量死亡增加。
  • 2016–2017年涉及处方阿片类和海洛因的死亡保持稳定。

临床怎么用

  • 更及时和全面的监测数据对指导和应对阿片类过量至关重要。
  • 亟需加强预防和应对措施以遏制处方和非法阿片类(特别是非法制造芬太尼)相关死亡。

局限性

  • 2018年临时数据提示部分药物过量指标可能改善,但需最终数据分析确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 63,632 drug overdose deaths in the United States in 2016 represented a 21.4% increase from 2015; two thirds of these deaths involved an opioid (1). From 2015 to 2016, drug overdose deaths increased in all drug categories examined; the largest increase occurred among deaths involving synthetic opioids other than methadone (synthetic opioids), which includes illicitly manufactured fentanyl (IMF) (1). Since 2013, driven largely by IMF, including fentanyl analogs (2-4), the current wave of the opioid overdose epidemic has been marked by increases in deaths involving synthetic opioids. IMF has contributed to increases in overdose deaths, with geographic differences reported (1). CDC examined state-level changes in death rates involving all drug overdoses in 50 states and the District of Columbia (DC) and those involving synthetic opioids in 20 states, during 2013-2017. In addition, changes in death rates from 2016 to 2017 involving all opioids and opioid subcategories,* were examined by demographics, county urbanization levels, and by 34 states and DC. Among 70,237 drug overdose deaths in 2017, 47,600 (67.8%) involved an opioid.† From 2013 to 2017, drug overdose death rates increased in 35 of 50 states and DC, and significant increases in death rates involving synthetic opioids occurred in 15 of 20 states, likely driven by IMF (2,3). From 2016 to 2017, overdose deaths involving all opioids and synthetic opioids increased, but deaths involving prescription opioids and heroin remained stable. The opioid overdose epidemic continues to worsen and evolve because of the continuing increase in deaths involving synthetic opioids. Provisional data from 2018 indicate potential improvements in some drug overdose indicators;§ however, analysis of final data from 2018 is necessary for confirmation. More timely and comprehensive surveillance data are essential to inform efforts to prevent and respond to opioid overdoses; intensified prevention and response measures are urgently needed to curb deaths involving prescription and illicit opioids, specifically IMF.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Scholl L, Seth P, Kariisa M, et al. Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30605448. doi:10.15585/mmwr.mm675152e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。